Pancreatitis in primary hyperparathyroidism-related hypercalcaemia is not associated with mutations in the CASR gene

P Felderbauer, E Karakas, V Fendrich… - Experimental and …, 2007 - thieme-connect.com
Background: Primary hyperparathyroidism (pHPT) related hypercalcaemia is considered to
represent a risk factor for the development of pancreatitis. We therefore explored whether …

Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives

TB Dru, E Ritz - Clinical journal of the American Society of …, 2009 - journals.lww.com
The discovery of the calcium-sensing receptor (CaR) 15 yr ago was rapidly followed by the
development of drugs modulating its activity, the so-called calcimimetics (increasing the …

Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and …

PH Nissen, SE Christensen… - The Journal of …, 2007 - academic.oup.com
Context: The autosomal dominantly inherited condition familial hypocalciuric hypercalcemia
(FHH) is characterized by elevated plasma calcium levels, relative or absolute hypocalciuria …

Cinacalcet reduces the set point of the PTH-calcium curve

C Valle, M Rodriguez, R Santamaría… - Journal of the …, 2008 - journals.lww.com
The calcimimetic cinacalcet increases the sensitivity of the parathyroid calcium-sensing
receptor to calcium and therefore should produce a decrease in the set point of the …

Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium …

T Kawata, Y Imanishi, K Kobayashi, N Onoda… - Journal of bone and …, 2006 - Springer
Clinical studies have been performed to determine the effect of cinacalcet HCl (cinacalcet),
an allosteric modulator of the calcium-sensing receptor (CaR), on primary …

Identification and functional analysis of novel calcium-sensing receptor gene mutation in familial hypocalciuric hypercalcemia

K Nanjo, S Nagai, C Shimizu, T Tajima, T Kondo… - Endocrine …, 2010 - jstage.jst.go.jp
Familial hypocalciuric hypercalcemia (FHH) is a benign disorder with heterozygous
inactivating mutations in the calcium-sensing receptor (CASR) gene. The present study …

[HTML][HTML] Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism

S Yano, T Sugimoto, T Tsukamoto, K Chihara… - Kidney international, 2000 - Elsevier
Association of decreased calcium-sensing receptor expression with proliferation of
parathyroid cells in secondary hyperparathyroidism. Background The down-regulation of …

[PDF][PDF] Experience with cinacalcet in familial hypocalciuric hypercalcemia resulting from inactivating mutations in calcium sensing receptor (CaSR)

J Anthonypillai, SK Sinha, A Mamkin, S Ten… - … Metab Int J, 2018 - researchgate.net
Background: Familial hypocalciuric hypercalcemia (FHH) is usually characterized by
asymptomatic hypercalcemia, hypocalciuria and normal PTH. The diagnosis of FHH is often …

Genetic variation at the calcium-sensing receptor (CASR) locus: implications for clinical molecular diagnostics

FHJ Yun, BYL Wong, M Chase, AY Shuen, L Canaff… - Clinical …, 2007 - Elsevier
OBJECTIVES:: The calcium-sensing receptor (CASR) is critical for maintenance of blood
calcium in a narrow physiologic range. Naturally occurring mutations in the calcium-sensing …

[HTML][HTML] Genetic polymorphism (rs6776158) in CaSR gene is associated with risk of nephrolithiasis in Chinese population

H Zhou, H Huang, Z You, K Shadhu, D Ramlagun… - Medicine, 2018 - journals.lww.com
Genetic polymorphism (rs6776158) in CaSR gene is associated... : Medicine Genetic
polymorphism (rs6776158) in CaSR gene is associated with risk of nephrolithiasis in …